News

Pharmaceutical Technology on MSN11h
BeOne Medicines’ BTK degrader gains EMA PRIME designation
The designation was based on the therapy’s novel mechanism and data showing its anti-tumour activity in B-cell malignancies.
Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1
CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...
Medscape2d
EMA Reverses Previous Refusal of Kisunla for Alzheimer's
Kisunla’s active substance is donanemab, a monoclonal antibody that targets and clears amyloid-beta plaques in the brain, a ...
DPA International on MSN7d
EMA recommends approval of additional Alzheimer's treatment
The European Medicines Agency (EMA) cleared the way for the use of another drug to treat Alzheimer's disease on Friday.
Moderna Reports Second Quarter 2025 Financial Results and Provides Business Updates
(NASDAQ:MRNA) today reported financial results and provided business updates for the second quarter of 2025. "In the last three months, we advanced our pipeline with positive Phase 3 flu vaccine ...
The Press Democrat6d
EU regulator green lights an injectable HIV drug that could help stop transmission
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug to prevent HIV. LONDON (AP) — The ...
Medscape3d
EMA Says No to Knee Cartilage Repair Therapy Jelrix
The European drug authority recommends refusal of marketing authorization due to evidence gaps in quality and efficacy.
Finanznachrichten1mon
Omeros Corporation: Omeros Submits Narsoplimab Marketing Authorization ...
The European Medicines Agency has granted orphan drug designation to narsoplimab for treatment in hematopoietic stem-cell transplant. About Hematopoietic stem cell transplant-associated thrombotic ...